Alphamin Res (AFM)
TSX Venture Exchange · Canada · prices in CAD · close of 27 Oct 2026
Key indicators
| Last close | CAD 1.290 |
|---|---|
| 52-week range | 0.990 – 1.680 |
| Return, 1 month / 3 months | −7.2% / −12.2% |
| Return, 1 year / 3 years | +39.1% / +91.0% |
| Trend | Below its 200-day average |
| RSI (14) | 35 |
| Volatility (1 year) | 56.7% |
| Worst drawdown (1 year) | -35.0% |
| Average daily value traded | 1.25M CAD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Alphamin Resources is a mining company that produces tin concentrate from its Bisie mine in the Democratic Republic of the Congo. The company explores for and extracts tin-bearing ore, processing it into concentrate that it supplies to smelters and industrial customers in international markets. Its operations are centred on the North Kivu region, and the business is managed from offices in Canada and Africa. Alphamin serves the global tin trade, where its output feeds into electronics and other manufacturing supply chains.
On this site Alphamin Res appears as a stock on the TSX Venture Exchange (Canada), code AFM, with prices in Canadian dollars (CAD). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Alphamin Res (AFM) trades on the TSX Venture Exchange in Canada. It last closed at CAD 1.290 on 27 October 2026.
Its price-based Market X-Ray is 81 out of 100 (a strong price profile), ranking 76 of 1,501 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 39.1% and over the last three months it fell 12.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on TSX Venture Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 79 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | -3.0% | ||
| From 52-week high | -22.3% | ||
| Momentum | 68 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -12.2% | ||
| 6-month return | 5.0% | ||
| 12-month return, skipping the last month | 49.8% | ||
| Stability (higher is calmer) | 86 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 56.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -35.0% | ||
| Liquidity | 99 · Strong | Trades actively. | |
| Average daily value traded | 1.25M CAD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −14.0% |
|---|---|
| 1 month | −7.2% |
| 3 months | −12.2% |
| 6 months | +5.0% |
| 1 year | +39.1% |
| 3 years | +91.0% |
| 5 years | +108.5% |
Signals
| 50-day / 200-day average | 1.439 / 1.329 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.054 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 22 May 2026 | MUR 0.1300 |
| 21 Nov 2025 | MUR 0.0400 |
| 29 Aug 2025 | MUR 0.0700 |
| 25 Oct 2024 | MUR 0.0600 |
| 16 May 2024 | MUR 0.0300 |
| 10 Aug 2023 | MUR 0.0300 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on TSX Venture Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.